Edition:
United States

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

124.20SEK
20 Jul 2018
Change (% chg)

0.80kr (+0.65%)
Prev Close
123.40kr
Open
127.60kr
Day's High
129.00kr
Day's Low
122.00kr
Volume
27,263
Avg. Vol
33,687
52-wk High
129.00kr
52-wk Low
82.00kr

Summary

Name Age Since Current Position

Gosta Johannesson

59 2018 Chairman of the Board

Magnus Nilsson

61 2016 Chief Executive Officer

Christoffer Rosenblad

42 2017 Deputy Chief Executive Officer, Chief Financial Officer

Karin Fischer

42 2016 Marketing and Sales Director USA

Emur Jensen

45 2016 Director of Development

Par-Ola Larsson

48 2016 Marketing and Sales Director Europe, Middle East, Africa and Pacific

Jenny Wennerberg

40 2016 Director of Quality Assurance and Regulatory Affairs

Yvonne Martensson

65 2018 Director

Alan Raffensperger

58 2018 Director

Folke Nilsson

67 Independent Director

Camilla Oberg

53 2016 Independent Director

Erik von Schenck

53 Independent Director

Biographies

Name Description

Gosta Johannesson

Mr. Gosta E. Johannesson has served as Chairman of the Board of Directors at Xvivo Perfusion AB since April 27, 2018. He has previously been Director of the Company. He holds Master of Science in Business Administration and Economics from Uppsala Universitet. He is senior advisor at Bure Equity AB. His other board assignments include board member in Interflora AB and Axiell Group as well as Chairman of the Board of Idevall & Partners Fonder AB, among others. He was earlier Partner at Provider Venture Partners, before that held executive position at Ohman Fondkommission and Handelsbanken Markets.

Magnus Nilsson

Dr. Magnus Nilsson has served as Chief Executive Officer (CEO) of Xvivo Perfusion AB since 2011. He no longer serves as Member of the Board of Directors of the Company effective as of May 3, 2016. Before that, he had served as CEO in Vitrolife since 2003. Previously, he was Project Leader for preclinical and clinical development at KaroBio AB and Pharmacia & Upjohn AB. He holds a Doctorate of Medical Sciences degree from Uppsala Universitet.

Christoffer Rosenblad

Mr. Christoffer Rosenblad has served as Chief Financial Officer at Xvivo Perfusion AB since 2012 and he has been Deputy Chief Executive Officer of the Company since July 17, 2017. Previously, he was Business Controller at Ciba Vision Nordic AB, and before that he held financial positions at LG Electronics. He holds Master of Science degree in Mechanical Engineering from Chalmers Tekniska Hogskola and a Bachelor of Science degree in Economics from Goteborgs Universitet.

Karin Fischer

Ms. Karin Fischer has been appointed Marketing and Sales Director USA at Xvivo Perfusion AB effective as of January 1, 2016. She has 15 years’ experience of the medical technology industry in several different clinical areas. Over the past 10 years she has held managerial positions in marketing and sales as well as quality at companies such as Johnson & Johnson and was Global Marketing and Communications Director of Getinge Infection Control. She holds Master of Science degree in Economics and Business Administration from Handelshogskolan at Linneuniversitetet and University of Aberdeen.

Emur Jensen

Mr. Emur Jensen has been appointed Director of Development at Xvivo Perfusion AB effective as of January 1, 2016. He has almost 20 years’ experience of leading positions within the development and manufacturing of medical technology products. Over the past three years Emur has been responsible for development of the XPS. He was previously plant manager at Vitrolife Inc. and before that he was responsible for technology- and process development at C&MI Inc. He holds a Bachelor of Science degree in Chemical Engineering. He has professional Engineer license in Colorado.

Par-Ola Larsson

Mr. Par-Ola Larsson has been appointed Marketing and Sales Director Europe, Middle East, Africa and Pacific at Xvivo Perfusion Aktiebolag effective as of January 1, 2016. He has many years’ experience of leading positions in the medical technology industry within sales, marketing and business development at companies such as Boston Scientific Inc. and Johnson & Johnson. He has been operative in the clinical areas of pulmonology, gastrology, thorax, sports medicines and neurovascular. He holds Master of Science degree in Economics and Business Administration from Handelskogskolan, Goteborgs Universitet and studied Management at Copenhagen Business School.

Jenny Wennerberg

Ms. Jenny Wennerberg has been appointed Director of Quality Assurance and Regulatory Affairs at Xvivo Perfusion AB effective as of January 1, 2016. Previously, she was QA/RA Manager at Integrum AB and before that 13 years´ experience with different Quality Assurance and R&D positions within medical device companies, such as Carmel Pharma AB and Astra Tech AB. She is Civil Engineer from Chalmers Tekniska Hogskola.

Yvonne Martensson

Alan Raffensperger

Folke Nilsson

Mr. Folke Nilsson serves as Independent Member of the Board of Directors of Xvivo Perfusion AB. He is Medical Doctor and holds a Doctorate in Philosophy degree from University of Gothenburg. He is specialist in cardiothoracic surgery. He was earlier responsible for Heart and Lung transplantation at Sahlgrenska Universitetssjukhuset. He is general practitioner.

Camilla Oberg

Ms. Camilla Oberg has been Independent Director of Xvivo Perfusion Aktiebolag since May 3, 2016. She holds Master of Science in Economics and Business Administration from Stockholm School of Economics. She has been CFO at Cybercom Group from 2012 and before that CFO in Logica Sweden. Before that, she held management positions in WM-data, SEB, Lexicon and Swegro Group. She is Board Member and Chairman of the Audit Committee in Black Earth Farming Ltd.

Erik von Schenck

Mr. Erik von Schenck serves as Independent Member of the Board of Directors of Xvivo Perfusion AB. He is Vice President and General Manager Circulatory solutions at Physio-Control, now part of Stryker. His other board assignments include such positions as Chairman of the Board in Avidicare AB, as well as Board Member in a number of smaller medtech companies. He has experience in the medical technology field through earlier assignments as Chief Executive Officer for Jolife AB and Jostra AB, as well as management positions in Gambro AB. He holds Master of Science degree in Civil Engineering from Lunds Universitet and an Executive Master of Business Administration degree.